HomeEXECUTIVES
EXECUTIVES
The medical device news magazine is the latest source for industry scoop. In this article, we take a look at which executives are on the move.
As the medical device industry rapidly expands, so does the need for executive leadership. Recently, several top executives have made moves within the industry. Some have taken new positions at other companies, while others have started their own businesses. Here’s a look at who’s been making headlines lately.
Sean Salmon Named EVP & President Cardiovascular Portfolio Effective January 1: Continues as EVP & President Diabetes Operating Unit
Sean Salmon is a highly respected leader both inside and outside of the company, with a proven track record of building and leading high-performing teams.
Chantal Le Chat Appointed to Robocath As An Independent Member of the Strategic Committee: Boasts 35 + Years of Skill
Over the last six years, she has occupied key strategic roles in the company’s Interventional Division, including Global GM. Her duties as an independent member of the Strategic Committee will include supporting the governance of Robocath.
Bigfoot Biomedical Helps People with Type 1 and 2 Diabetes: Company Announces Impressive New Hires with Strong Device Experience
Together, Nelson and his new team represent a wealth of experience and knowledge in the medical device space and operationalizing a provider reimbursement and services model.
Charles Huiner Named CEO of Modulim: Brings 25+ Years of Executive Experience From Across Multiple Life Science Segments
Huiner will start immediately and lead the Company’s Series C fundraising and execution of a focused growth strategy for its FDA-cleared product, Clarifi®.
SOLIUS New World-class Talent and Scientific Leadership Team
Wise said, “Our team has never been more focused, and we are tremendously excited about the products we are developing and their impact on the health of everyone around us.”
Stealth BioTherapeutics Announces Appointment of Eve E. Slater, M.D., F.A.C.C. to its Board of Directors: Highly Experienced Cardiovascular Medical Expert and Executive
Dr. Slater has served as Senior Vice President for Worldwide Policy, Pfizer, Inc., Assistant Secretary for Health in the US Department of Human Services, and Senior Vice President of Clinical and Regulatory Development, and SVP of External Policy of Merck and Co.
Kevin Muir Becomes New VP, Commercial Operations of Delcath Systems: Experienced and Seasoned Leader
Muir was Director of Sales for the Embolics Interventional Oncology business unit of BTG plc where he played a key role in growing that business from $40 million to $180 million at which time BTG was acquired by Boston Scientific.
Kevin Ballinger Appointed to Silk Road Medical’s Board of Directors: Brings Decades of Medical Device Industry Experience
Ballinger, the recently appointed Chief Executive Officer of Aldevron, brings decades of experience in the medical device industry.
Jennifer Esposito Appointed to VivaLNK Board of Directors: Over 20 Years of Experience, Esposito Will Advise the Executive Team and Assist in Growth in...
Esposito's vast experience in the healthcare technology and medical device fields will provide VivaLNK and its executive team a valuable resource to help direct the company's strategic growth as it powers the world's leading RPM (remote patient monitoring) technologies.
